COMMUNIQUÉS West-GlobeNewswire

Bicara Therapeutics Presents Phase 1/1b Dose Expansion Results with Ficerafusp Alfa in Advanced Squamous Cancer of the Anal Canal at the 2025 ASCO Gastrointestinal Cancers Symposium
27/01/2025
BOSTON, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, [...]
Life Biosciences Appoints Dr. Michael Ringel as Chief Operating Officer
27/01/2025
BOSTON, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Life Biosciences (“Life Bio”), a biotechnology company pioneering cellular rejuvenation therapies to reverse and prevent multiple diseases of aging, today announced the [...]
Aspargo Labs Appoints Harold D. Tamayo as Chief Financial Officer
27/01/2025
Experienced financial leader joins as the company prepares for its public market entry NEW YORK, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Aspargo Labs, Inc., (“Aspargo Labs” or the “Company”), a specialty pharmacy and MedTech [...]
Stereotaxis Receives CE Mark Approval for the MAGiC Ablation Catheter
27/01/2025
ST. LOUIS, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it received European CE Mark [...]
iCAD Pre-Announces Estimated Q4 2024 Revenue
27/01/2025
iCAD to Participate in the BTIG at Snowbird: 12 th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference NASHUA, N.H., Jan. 27, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the [...]
Entera Bio to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
27/01/2025
JERUSALEM, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides and therapeutic proteins, announced that it will [...]
Acuitive Technologies, Inc. Appoints Dr. Wayne Berberian as Chief Medical Officer
27/01/2025
Acuitive Technologies announces the appointment of Dr. Wayne Berberian as Chief Medical Officer. In this role, Dr. Berberian will drive the company’s strategy behind new product development of first-in-class [...]
Dentzz Dental Reports Serving Over 100,000 Patients Worldwide, Highlighting Dental Tourism Trends
25/01/2025
Photo credit: Dentzz Dental MUMBAI, India, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Dentzz Dental, a leading provider of advanced dental care, has announced that it has served over 100,000 patients worldwide since its founding [...]
Tevogen Bio Broadens Relationship with Microsoft to Deepen Artificial Intelligence Collaboration and Develop PredicTcell Technology on Azure
24/01/2025
This expansion is in addition to the previously announced Microsoft for Startups program. PredicTcell, Tevogen Bio’s proprietary technology, is designed for predictive, precision T cell target identification. Tevogen [...]
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
24/01/2025
MALVERN, Pa., Jan. 24, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today [...]
Akero Therapeutics to Present Preliminary Topline Week 96 Results from Phase 2b SYMMETRY Study Investigating Efruxifermin in Patients with Compensated Cirrhosis (F4) Due to MASH
24/01/2025
Investor webcast on Monday, January 27, 2025, at 8:00 a.m. ET to present clinical data SOUTH SAN FRANCISCO, Calif., Jan. 24, 2025 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company [...]
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
24/01/2025
DURHAM, N.C., Jan. 24, 2025 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), today announced that on January 17, 2025, the Compensation Committee of Chimerix’s Board of Directors granted inducement awards to six new [...]
Half-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux
24/01/2025
Daix (France), New York City (New York, United States), January 24, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development [...]
Bilan semestriel du contrat de liquidité de la société Inventiva conclu avec Kepler Cheuvreux
24/01/2025
Daix (France), New York City (New York, Etats-Unis), le 24 janvier 2025 – Inventiva (Euronext Paris and Nasdaq : IVA) (la « Société »), société biopharmaceutique spécialisée dans le développement clinique de petites [...]
Press release: Sequana Medical Announces New Share Capital Amount and New Number of Shares following Loan Conversions
24/01/2025
SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES FOLLOWING LOAN CONVERSIONS Conversion of EUR 0.53 million under the Sensinnovat 2020 loan, EUR 1.28 million under the 2024 convertible loan [...]
AB Science will host a live webcast on Tuesday January 28, 2025, from 5.30pm to 6.45pm CET
24/01/2025
PRESS RELEASE AB SCIENCE WILL HOST A LIVE WEBCAST ON TUESDAY JANUARY 28, 2025 FROM 5.30PM TO 6.45PM CET Paris, 24 January 2025, 6pm CET AB Science SA (Euronext – FR0010557264 – AB) will host a live webcast on Tuesday [...]
AB Science tiendra une conférence virtuelle le mardi 28 janvier 2025, de 17h30 à 18h45
24/01/2025
COMMUNIQUE DE PRESSE AB SCIENCE TIENDRA UNE CONFERENCE VIRTUELLE LE MARDI 28 JANVIER 2025, DE 17H30 A 18H45 Paris, 24 janvier 2025, 18h AB Science SA (Euronext – FR0010557264 – AB) tiendra une conférence virtuelle le [...]
Elevar Therapeutics Presents Results from Post-Hoc Analysis of CARES-310 Study Evaluating the Impact of Viral and Non-Viral Etiology on Survival in Hepatocellular Carcinoma
24/01/2025
Post-hoc analysis on survival outcomes for camrelizumab plus rivoceranib in patients with viral and non-viral hepatocellular carcinoma (HCC) demonstrated clinically meaningful overall survival and progression-free [...]
Beyond Air® Announces LungFit® PH Receives Market Authorization in Australia
24/01/2025
GARDEN CITY, N.Y., Jan. 24, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of [...]

Pages